Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
June 27, 2023
0Patent Application Number
173384200
Date Filed
June 3, 2021
0Patent Citations
...
Patent Citations Received
Patent Primary Examiner
CPC Code
The present disclosure relates generally to various forms, salts and compositions of compounds useful for the modulation of one or more interleukin-1 receptor-associated kinases (“IRAK”) via ubiquitination and/or degradation and uses of the same in the treatment various diseases.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
